New dimension in drug addiction therapy

Basic and Clinical Neuroscience

Volumn 1, Issue 4, 2010, Pages 68-69

  Zarrindast, Mohammad Reza ^c   Sahraei, Hedayat ^a,d   Dejakam, Hossein ^b  

^a Faculty of Medicine   (Iran)

^b South Sohravardi Street ^*  (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; STRESS HORMONE;

ARTICLE; BRAIN FUNCTION; CLINICAL EFFECTIVENESS; DETOXIFICATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; HORMONE RELEASE; HUMAN; METHADONE TREATMENT; RAPID DETOXIFICATION; STRESS; TREATMENT OUTCOME; ULTRA RAPID DETOXIFICATION;

EID: 84937479468     PISSN: 2008126X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Beitner-Johnson, D., Guitart, X. and Nestler, EJ. (1992). Common intracellular actions of chronic morphine and cocaine in dopaminergic brain reward regions. Ann. NY. Acad. Sci, 654, 70-87.
2. Koob, GF. (2009). Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry, 42, S32-41.
3. Koob, GF. and Le Moal, M. Addiction and the brain antireward system. Annu. Rev. Psychol, 59, 29-53.
4. Kreek, MJ., Borg, L., Ducat, E., Ray, B. (2008). Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis, 29, 200-216.
5. Nestler, EJ. (1994). Molecular neurobiology of drug addiction. Neuropsychopharmacology 11, 77-87.
6. Self, DW. and Nestler. EJ. (1995). Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci.18, 463-495.